Overview
Highlights
- 1Scientific reports · 2024
- 2Scientific reports · 2022
- 3Menopause (New York, N.Y.) · 2025
Publications
Funding
Active
4 grants- PITransforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat ADNIA · 2026–2031 · via NIH RePORTERU01AG095263-01
- Sub-PIPhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical TrialNational Institute on Aging · 2022–2027 · via University of ArizonaR01AG075122-04
- Sub-PIPerimenopause in Brain Aging and Alzheimer's diseaseNational Institute on Aging · 2016–2026 · via University of Arizona· 3 renewalsP01AG026572-19
- KPNew PET/CT System for Human and Non-human Primate ImagingOffice of the Director, NIH · 2023–2026S10OD034271-01
Completed grants (12)
- KP7T Magnetic Resonance Imaging System for Basic, Translational and Clinical ResearchOffice of the Director, NIH · 2021–2025
- Sub-PISex Differences in the Molecular Determinants of Alzheimer’s Disease RiskNational Institute on Aging · 2018–2024 · via University of Arizona· 2 renewalsR01AG057931-05
- Sub-PIModifiable cardiovascular factors linking type 2 diabetes and Alzheimer'sNational Institute on Aging · 2018–2024 · via New York UniversityR01AG055624-05
- MPIClinical and Translational Science Center- Institutional CTSC Internal Funding UL1CTSC Cost Share · 2017–2022CTSC Internal Funding UL1
- Sub-PINeuroenergetic Adaptations in Alzheimer's Disease: Implications on Amyloid Burden and CognitionNational Institute on Aging · 2019–2022 · via New York University School of Medicine (Grossman)R21AG061579-02
- PIADMdx Statement of WorkADM Diagnostics, Inc. (ADMdx) · 2020–2022ContractSA 202163-01
- PIAlzheimer’s risk is higher in women: identification of female-specific bioenergetic targetsCure Alzheimer’s Fund · 2018–2021CAF 183574-02
- Co-IUnderstanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's DiseaseNational Institute on Aging · 2019–2021R56AG064873-01
- MPIHistory of Alzheimer predisposes children to amyloid beta-related hypometabolismNIA · 2010–2017 · via NIH RePORTERR01AG035137-05
- PIPRECLINICAL DETECTION OF AD (ABBREAVIATE AS FAMHXAD)NCRR · 2011–2012 · via NIH RePORTERP41RR013642-14
- PIFamily History of Alzheimer's, Hypometabolism and Oxidative StressNIA · 2008–2011 · via NIH RePORTERR21AG032554-02
Clinical research
Active
1 study- PINCT05664477PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical TrialPHASE2 · University of Arizona · OPEN TO ACCRUAL (as of 2023)Menopause; Cognitive Change; Brain Disorder, Metabolic
News mentions
- Scans Show Brain's Estrogen Activity Changes During MenopauseJune 20, 2024
The transition to menopause is marked by a progressively higher density of estrogen receptors (ER) on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study led by researchers at Weill Cornell Medicine.
- Study Suggests Estrogen to Prevent Alzheimer’s Warrants Renewed Research InterestOctober 23, 2023
Estrogen-based menopause hormone therapy for women in mid-life should be investigated more thoroughly as a potential strategy for preventing Alzheimer’s disease, the most common form of dementia, according to a new analysis from researchers at Weill Cornell Medicine.
- For Women, Greater Exposure to Estrogen in Life May Protect Brain Regions That Are Vulnerable to Alzheimer’sNovember 3, 2021
The drop in estrogen levels that occurs with menopause brings declines in the volumes of “gray matter,” the cellular matter of the brain, in key brain regions that are also affected in Alzheimer’s disease. But a new study from Weill Cornell Medicine researchers, in collaboration with the University of Arizona, suggests that greater cumulative exposure to estrogen in life
- Imaging Study Reveals Brain Changes During the Transition to MenopauseJune 9, 2021
The transition from pre- to post-menopause, with its steep decline in estrogen production, involves myriad changes to brain structure, brain-region connectivity, and brain energy consumption, though many of these changes are only temporary, a study led by researchers at Weill Cornell Medicine has found.
- New Study Indicates Women Develop Brain Changes Associated with Alzheimer’s Disease Earlier than MenJune 24, 2020
The hormonal shifts that occur with menopause can increase the risk of brain changes associated with Alzheimer’s disease, according to new research from Weill Cornell Medicine investigators.
Show 1 more mention
- Gender DisparityApril 10, 2019
Neuroscientist Dr. Lisa Mosconi explores why women have a much higher risk of Alzheimer’s disease than men.
Media highlights
- At 58, I Had Early Signs Of Alzheimer’s In My Brain. These Interventions Got Rid Of ThemTODAY · November 3, 2026
- Women Have A Higher Risk For Alzheimer’s Than Men Do—Experts Explain Why, And How You Can Protect Your BrainPrevention · September 25, 2026
- Hormone Replacement Therapy: When Is It Good For The Brain?Alzforum · September 24, 2026